Showing results (211-220 of 221) with videos related to
Sort By:
Pageof 23
Neurology|January 11, 2008
Progranulin genetic variability contributes to amyotrophic lateral sclerosisK Sleegers, N Brouwers, S Maurer-Stroh, et al.Journal of Viral Hepatitis|March 7, 2018
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in EuropeG V Papatheodoridis, A Hatzakis, E Cholongitas, et al.Epidemiology and Infection|December 24, 2008
A comparison of hepatitis B seroepidemiology in ten European countriesA Nardone, C G Anastassopoulou, H Theeten, et al.Vaccine|October 9, 2007
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European regionA Nardone, F de Ory, M Carton, et al.The Journal of Infectious Diseases|November 24, 1999
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccineS Frey, R Dagan, Y Ashur, et al.Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.Journal of Viral Hepatitis|August 10, 2011
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*A Hatzakis, S Wait, J Bruix, et al.Journal of Viral Hepatitis|July 6, 2013
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conferenceA Hatzakis, P Van Damme, K Alcorn, et al.Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.Pageof 23